FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783456772> ?p ?o ?g. }

• W2783456772 endingPage "624" @default.
• W2783456772 startingPage "614" @default.
• W2783456772 abstract "Abstract Internal tandem duplication (ITD) or tyrosine kinase domain mutations of FLT3 is the most frequent genetic alteration in acute myelogenous leukemia (AML) and are associated with poor disease outcome. Despite considerable efforts to develop single-target FLT3 drugs, so far, the most promising clinical response has been achieved using the multikinase inhibitor midostaurin. Here, we explore the activity of the indolocarbazole EC-70124, from the same chemical space as midostaurin, in preclinical models of AML, focusing on those bearing FLT3-ITD mutations. EC-70124 potently inhibits wild-type and mutant FLT3, and also other important kinases such as PIM kinases. EC-70124 inhibits proliferation of AML cell lines, inducing cell-cycle arrest and apoptosis. EC-70124 is orally bioavailable and displays higher metabolic stability and lower human protein plasma binding compared with midostaurin. Both in vitro and in vivo pharmacodynamic analyses demonstrate inhibition of FLT3-STAT5, Akt-mTOR-S6, and PIM-BAD pathways. Oral administration of EC-70124 in FLT3-ITD xenograft models demonstrates high efficacy, reaching complete tumor regression. Ex vivo, EC-70124 impaired cell viability in leukemic blasts, especially from FLT3-ITD patients. Our results demonstrate the ability of EC-70124 to reduce proliferation and induce cell death in AML cell lines, patient-derived leukemic blast and xenograft animal models, reaching best results in FLT3 mutants that carry other molecular pathways' alterations. Thus, its unique inhibition profile warrants EC-70124 as a promising agent for AML treatment based on its ability to interfere the complex oncogenic events activated in AML at several levels. Mol Cancer Ther; 17(3); 614–24. ©2018 AACR." @default.
• W2783456772 created "2018-01-26" @default.
• W2783456772 creator A5011471365 @default.
• W2783456772 creator A5012919016 @default.
• W2783456772 creator A5026592803 @default.
• W2783456772 creator A5028634268 @default.
• W2783456772 creator A5046936586 @default.
• W2783456772 creator A5048785159 @default.
• W2783456772 creator A5056454399 @default.
• W2783456772 creator A5058341838 @default.
• W2783456772 creator A5068607171 @default.
• W2783456772 creator A5072282435 @default.
• W2783456772 creator A5072404351 @default.
• W2783456772 creator A5079200881 @default.
• W2783456772 creator A5080491176 @default.
• W2783456772 date "2018-02-28" @default.
• W2783456772 modified "2023-10-16" @default.
• W2783456772 title "Inhibition of FLT3 and PIM Kinases by EC-70124 Exerts Potent Activity in Preclinical Models of Acute Myeloid Leukemia" @default.
• W2783456772 cites W1629179716 @default.
• W2783456772 cites W1662899804 @default.
• W2783456772 cites W1829278331 @default.
• W2783456772 cites W1968306285 @default.
• W2783456772 cites W1979196526 @default.
• W2783456772 cites W1981229807 @default.
• W2783456772 cites W1983887345 @default.
• W2783456772 cites W1996307710 @default.
• W2783456772 cites W2007613815 @default.
• W2783456772 cites W2009816863 @default.
• W2783456772 cites W2011853681 @default.
• W2783456772 cites W2021619817 @default.
• W2783456772 cites W2021759592 @default.
• W2783456772 cites W2027145130 @default.
• W2783456772 cites W2029815493 @default.
• W2783456772 cites W2037654078 @default.
• W2783456772 cites W2041779329 @default.
• W2783456772 cites W2051815726 @default.
• W2783456772 cites W2066652302 @default.
• W2783456772 cites W2068605060 @default.
• W2783456772 cites W2089899349 @default.
• W2783456772 cites W2099825600 @default.
• W2783456772 cites W2100136475 @default.
• W2783456772 cites W2109078622 @default.
• W2783456772 cites W2130197839 @default.
• W2783456772 cites W2146265383 @default.
• W2783456772 cites W2146827511 @default.
• W2783456772 cites W2149109263 @default.
• W2783456772 cites W2157499839 @default.
• W2783456772 cites W2171218023 @default.
• W2783456772 cites W2173764977 @default.
• W2783456772 cites W223219687 @default.
• W2783456772 cites W2260051349 @default.
• W2783456772 cites W2319831517 @default.
• W2783456772 cites W2715749014 @default.
• W2783456772 cites W78744612 @default.
• W2783456772 cites W95524412 @default.
• W2783456772 doi "https://doi.org/10.1158/1535-7163.mct-17-0530" @default.
• W2783456772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29339551" @default.
• W2783456772 hasPublicationYear "2018" @default.
• W2783456772 type Work @default.
• W2783456772 sameAs 2783456772 @default.
• W2783456772 citedByCount "13" @default.
• W2783456772 countsByYear W27834567722019 @default.
• W2783456772 countsByYear W27834567722020 @default.
• W2783456772 countsByYear W27834567722022 @default.
• W2783456772 countsByYear W27834567722023 @default.
• W2783456772 crossrefType "journal-article" @default.
• W2783456772 hasAuthorship W2783456772A5011471365 @default.
• W2783456772 hasAuthorship W2783456772A5012919016 @default.
• W2783456772 hasAuthorship W2783456772A5026592803 @default.
• W2783456772 hasAuthorship W2783456772A5028634268 @default.
• W2783456772 hasAuthorship W2783456772A5046936586 @default.
• W2783456772 hasAuthorship W2783456772A5048785159 @default.
• W2783456772 hasAuthorship W2783456772A5056454399 @default.
• W2783456772 hasAuthorship W2783456772A5058341838 @default.
• W2783456772 hasAuthorship W2783456772A5068607171 @default.
• W2783456772 hasAuthorship W2783456772A5072282435 @default.
• W2783456772 hasAuthorship W2783456772A5072404351 @default.
• W2783456772 hasAuthorship W2783456772A5079200881 @default.
• W2783456772 hasAuthorship W2783456772A5080491176 @default.
• W2783456772 hasBestOaLocation W27834567722 @default.
• W2783456772 hasConcept C101544691 @default.
• W2783456772 hasConcept C104317684 @default.
• W2783456772 hasConcept C150903083 @default.
• W2783456772 hasConcept C184235292 @default.
• W2783456772 hasConcept C190283241 @default.
• W2783456772 hasConcept C203014093 @default.
• W2783456772 hasConcept C207001950 @default.
• W2783456772 hasConcept C2776481607 @default.
• W2783456772 hasConcept C2778461978 @default.
• W2783456772 hasConcept C2778729363 @default.
• W2783456772 hasConcept C2910954276 @default.
• W2783456772 hasConcept C42362537 @default.
• W2783456772 hasConcept C501734568 @default.
• W2783456772 hasConcept C502942594 @default.
• W2783456772 hasConcept C55493867 @default.
• W2783456772 hasConcept C62478195 @default.
• W2783456772 hasConcept C75217442 @default.
• W2783456772 hasConcept C86803240 @default.

• next